BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 11302148)

  • 1. Schistosoma haematobium.
    Reich MR; Fenwick A
    N Engl J Med; 2001 Apr; 344(15):1170. PubMed ID: 11302148
    [No Abstract]   [Full Text] [Related]  

  • 2. Therapeutic and operational profiles of metrifonate and praziquantel in Schistosoma haematobium infection.
    Feldmeier H; Chitsulo L
    Arzneimittelforschung; 1999 Jul; 49(7):557-65. PubMed ID: 10442201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Schistosoma haematobium infection and morbidity before and after large-scale administration of praziquantel in Burkina Faso.
    Koukounari A; Gabrielli AF; Toure S; Bosque-Oliva E; Zhang Y; Sellin B; Donnelly CA; Fenwick A; Webster JP
    J Infect Dis; 2007 Sep; 196(5):659-69. PubMed ID: 17674306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patterns of reinfection following praziquantel treatment of urinary schistosomiasis at a period of low transmission.
    Ofoezie IE
    Acta Trop; 2000 Feb; 75(1):123-6. PubMed ID: 10708014
    [No Abstract]   [Full Text] [Related]  

  • 5. Praziquantel treatment of individuals exposed to Schistosoma haematobium enhances serological recognition of defined parasite antigens.
    Mutapi F; Burchmore R; Mduluza T; Foucher A; Harcus Y; Nicoll G; Midzi N; Turner CM; Maizels RM
    J Infect Dis; 2005 Sep; 192(6):1108-18. PubMed ID: 16107967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of praziquantel on the uro-nephrologic complications of urinary bilharziasis].
    Rasendramino MH; Rajaona HR; Ramarokoto CE; Ravaoalimalala VE; Leutscher P; Cordonnier D; Esterre P
    Nephrologie; 1998; 19(6):347-51. PubMed ID: 9836197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of praziquantel and metrifonate on Schistosoma bovis infections in Sudanese cattle.
    Bushara HO; Hussein MF; Majid MA; Taylor MG
    Res Vet Sci; 1982 Jul; 33(1):125-6. PubMed ID: 7134640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Long-term impact of a mass treatment by praziquantel on morbidity due to Schistosoma haematobium in two hyperendemic villages of Niger].
    Garba A; Campagne G; Tassie JM; Barkire A; Vera C; Sellin B; Chippaux JP
    Bull Soc Pathol Exot; 2004 Feb; 97(1):7-11. PubMed ID: 15104149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Female Genital Schistosomiasis.
    Hotez PJ; Engels D; Gyapong M; Ducker C; Malecela MN
    N Engl J Med; 2019 Dec; 381(26):2493-2495. PubMed ID: 31881137
    [No Abstract]   [Full Text] [Related]  

  • 10. Praziquantel and oltipraz: the treatment of schoolchildren infected with Schistosoma mansoni and/or Schistosoma haematobium in Gezira, Sudan.
    el Tayeb M; Daffalla AA; Kardaman MW; See R; Fenwick A
    Ann Trop Med Parasitol; 1988 Feb; 82(1):53-7. PubMed ID: 3135786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-4, immunoglobulin E and immunoglobulin A and resistance to re-infection with Schistosoma haematobium before and after chemotherapy.
    Khalil HM; Abd el Baki MH; Abd el Mawla MM; Maklad KM; Sharaf SA; Saad AE
    J Egypt Soc Parasitol; 1999 Aug; 29(2):395-408. PubMed ID: 10605492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Schistosomiasis in an American medical investigator.
    Young D; Beland JE; Kloos H; Higashi GI; Heyneman D
    J Clin Gastroenterol; 1986 Oct; 8(5):589-93. PubMed ID: 3097117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minimal change glomerulonephritis associated with Schistosoma hematobium infection--resolution with praziquantel treatment.
    Turner I; Ibels LS; Alexander JH; Harrison A; Moir D
    Aust N Z J Med; 1987 Dec; 17(6):596-8. PubMed ID: 3128971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Praziquantel--its use, cost and possible development of resistance.
    Kusel J; Hagan P
    Parasitol Today; 1999 Sep; 15(9):352-4. PubMed ID: 10461159
    [No Abstract]   [Full Text] [Related]  

  • 15. Schistosomiasis: new therapies for an old disease.
    Imperato PJ
    N Y State J Med; 1983; 83(11-12):1147-8. PubMed ID: 6358968
    [No Abstract]   [Full Text] [Related]  

  • 16. The chemotherapy of schistosomiasis control.
    Bull Pan Am Health Organ; 1986; 20(1):68-9. PubMed ID: 3768593
    [No Abstract]   [Full Text] [Related]  

  • 17. Schistosoma haematobium treatment with praziquantel: preliminary clinical observations.
    Woldemichael T; Wondimagegnehu T
    Ethiop Med J; 1986 Jul; 24(3):155-6. PubMed ID: 3087746
    [No Abstract]   [Full Text] [Related]  

  • 18. Chemotherapy accelerates the development of acquired immune responses to Schistosoma haematobium infection.
    Mutapi F; Ndhlovu PD; Hagan P; Spicer JT; Mduluza T; Turner CM; Chandiwana SK; Woolhouse ME
    J Infect Dis; 1998 Jul; 178(1):289-93. PubMed ID: 9652458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of bilharziasis due to Schistosoma haematobium infection.
    Blair DM
    Cent Afr J Med; 1977 Nov; 23(11 Suppl):23-5. PubMed ID: 606375
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of praziquantel on the immature stages of Schistosoma haematobium.
    Botros S; Pica-Mattoccia L; William S; El-Lakkani N; Cioli D
    Int J Parasitol; 2005 Nov; 35(13):1453-7. PubMed ID: 16002073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.